The effect of lithium on the immune system

Human Psychopharmacology

Volumn 14, Issue 5, 1999, Pages 345-353

  Rybakowski, Janusz K ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Affective disorders; Depression; Herpes virus; Immune function; Lithium

Indexed keywords

ANTIDEPRESSANT AGENT; FLUOXETINE; LITHIUM; LITHIUM CARBONATE; MONOAMINE OXIDASE INHIBITOR; SUCCINATE LITHIUM; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT;

AFFECTIVE NEUROSIS; ANTIVIRAL ACTIVITY; CELLULAR IMMUNITY; DEPRESSION; DRUG POTENTIATION; GENITAL HERPES; HERPES VIRUS; HUMAN; HUMORAL IMMUNITY; IMMUNE SYSTEM; IMMUNOMODULATION; IMMUNOPATHOLOGY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; TOPICAL DRUG ADMINISTRATION; VIRUS INFECTION;

EID: 0032817463     PISSN: 08856222     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1077(199907)14:5<345::AID-HUP105>3.0.CO;2-T     Document Type: Review

References (65)

1. Agarwal, S. N., Chaterjee, B., Tripathi, B. N. and Chandra, R. (1989). Role of lithium carbonate in pancytopenia following cytotoxic therapy. Journal of Indian Medical Association, 87, 115-116.
2. Amsterdam, J. D., Winokur, A., Dyson, W., Herzog, S., Gonzalez, F., Rott, R. and Koprowski, H. (1985). Borna disease virus. A possible etiologic factor in human affective disorders. Archives of General Psychiatry, 42, 1093-1096.
3. Amsterdam, J. D., Henle, W., Winokur, A., Wolkowitz, O. M., Pickar, D. and Paul, S. M. (1986). Serum antibodies to Epstein-Barr virus in patients with major depressive disorder. American Journal of Psychiatry, 143, 1593-1596.
4. Amsterdam, J. D., Maislin, G., Potter, L., Giountoli, R. and Koprowski, H. (1991). Suppression of genital herpes infections with lithium carbonate: a randomized, placebo-controlled trial. Lithium, 2, 17-25.
5. Amsterdam, J. D., Maislin, G. and Rybakowski, J. K. (1995). Possible suppression of herpes simplex virus infections with oral lithium carbonate. Malta Lithium Symposium Abstracts. Journal of Trace and Microprobe Techniques, 13, 492.
6. Anand, A., Malison, R., McDougle, C. J. and Price, L. H. (1995). Antiglucocorticoid treatment of refractory depression with ketokonazole: a case report. Biological Psychiatry, 37, 338-340.
7. Bach, R. O. and Specter, S. (1988). Antiviral activity of lithium ion with adjuvant agents. In Lithium: Inorganic Pharmacology and Psychiatric Use, Birch, N. J. (Ed.), IRL Press, Oxford, pp. 83-90.
8. Baştürk, M., Sofouǧlu, S., Karaaslan, F., Tutus, A., Yabanoǧlu, I. and Gönül, A. S. (1998). Effects of short and long-term lithium treatment on serum cortisol levels in patients with bipolar affective disorder. European Neuropsychopharmacology, 8(suppl. 2), S196.
9. Bode, L., Dürnwald, R., Rantam, F. A., Ferszt, R. and Ludwig, H. (1996). First isolates of infectious human Borna disease virus from patients with mood disorders. Molecular Psychiatry, 1, 200-212.
10. Bode, L., Dietrich, D. F., Stoyloff, R., Emrich, H. M. and Ludwig, H. (1997). Amantadine and human Borna disease virus in vitro and in vivo in an infected patients with bipolar depression. Lancet, 349, 178.
11. Brewerton, T. D. (1986). Lithium counteracts carbamazepine-induced leukopenia while increasing its therapeutic effect. Biological Psychiatry, 21, 677-685.
12. Buchan, A., Randall, S., Hartley, C. E., Skinner, G. R. B. and Fuller, A. (1988). Effect of lithium salts on the replication of viruses and non-viral microorganisms. In Lithium: Inorganic Pharmacology and Psychiatric Use. IRL Press, Oxford, pp. 83-90.
13. Cappel, R., Gregoire, F., Thiry, L. and Sprecher, S. (1978). Antibody and cell-mediated immunity to herpes simplex virus in psychotic depression. Journal of Clinical Psychiatry, 39, 266-268.
14. Christiansen, P., Lolk, A. and Gram, L. F. (1989). Cortisol and treatment of depression: predictive value of spontaneous and suppressed cortisol levels and the course of spontaneous plasma cortisol. Psychopharmacology, 97, 471-475.
15. Connor, T. J. and Leonard, B. F. (1998). Depression, stress and immunological activation: the role of cytokines in depressive disorders. Life Sciences, 62, 583-606.
16. Dosch, H. M., Matheson, D., Shurman, R. and Gelfand, E. (1980). Antisuppressor cell effect of lithium in vitro and in vivo. In Lithium Effects on Granulopoiesis and Immune Function, Rossof, A. and Robinson, W. (Eds), Plenum Press, New York, pp. 463-469.
17. Evans, D. L., Pedersen, C. A. and Folds, J. D. (1988). Major depression and immunity: preliminary evidence of decreased natural killer activity cell populations. Progress of Neuro-Psychopharmacology and Biological Psychiatry, 12, 739-748.
18. Gillis, A. (1983). Lithium in herpes simplex. Lancet, ii, 516.
19. Glaser, R., Kielcolt-Glaser, J. K., Speicher, C. E. and Holiday, J. E. (1985). Stress, loneliness and changes in herpes virus latency. Journal of Behavioral Medicine, 8, 249-260.
20. Gold, P. W., Chrousos, G., Keller, C., Post, R., Roy, A., Augerinos, P., Schulte, H., Oldfield, E. and Loriaux, D. L. (1994). Psychiatric implications of basic and clinical studies with corticotropic-releasing factor. American Journal of Psychiatry, 141, 619-627.
21. Horrobin, D. F. (1985). Lithium in the control of herpesvirus infections. In Lithium. Current Applications in Science, Medicine and Technology, Bach, R. O. (Ed.), John Wiley & Sons, New York, pp. 397-406.
22. Jones, J. F., Ray, C. G., Minnich, L. L., Hicks, M. J., Kibler, R. and Lucas, D. O. (1985). Evidence for active Epstein-Barr virus infection in patients with persistent, unexplained illness: elevated anti-early antigen antibodies. Annals of Internal Medicine, 102, 1-7.
23. Kriesel, J. D., Ricigliano, J., Spruance, S. L., Garza, H. H. and Hill, J. H. (1997). Neuronal reactivation of herpes simplex virus may involve interleukin-6. Journal of NeuroVirology, 3, 441-448.
24. Kucharz, E. J., Sierakowski, S., Staite, N. D. and Goodwin, J. S. (1988). Mechanism of lithium-induced augmentation of T-cell proliferation. International Journal of Immunopharmacology, 10, 253-259.
25. Lennox, R. H., McNamara, R. K., Papke, R. L. and Manji, H. K. (1998). Neurobiology of lithium: an update. Journal of Clinical Psychiatry, 59 (supp. 6), 37-47.
26. Lieb, J. (1979). Remission of recurrent herpes infection during therapy with lithium. New England Journal of Medicine, 301, 942.
27. Lycke, E., Norrby, R. and Roos, B.-E. (1974). A serological study on mentally ill patients with particular reference to the prevalence of herpes virus infections. British Journal of Psychiatry, 124, 273-279.
28. Maes, M., Scharpe, S., Bosmans, E., Vandewoude, M., Suy, E., Uyttenbroeck, W., Cooreman, W., Vandervorst, C. and Raus, J. (1992a). Disturbances in acute phase plasma proteins during melancholia: additional evidence for the presence of an inflammatory process during that illness. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 16, 501-515.
29. Maes, M., Van der Planken, M., Stevens, J. W., Peeters, D., de Clerck, L. S., Bridts, C. H., Schotte, C. and Cosyns, P. (1992b). Leukocytosis, monocytosis and neutrophilia: hallmarks of severe depression. Journal of Psychiatric Research, 26, 125-134.
30. Maes, M., Wautwers, A., Neels, H., Scharpe, S., Van gastel, A., Dhondt, P., Peeters, D., Cosnys, P. and Desnyder, R. (1995). Total serum protein and serum protein fractions in depression: relationships to depressive symptoms and glucocorticoid activity. Journal of Affective Disorders, 34, 61-69.
31. Maes, M., Delange, J., Ranjan, R., Meltzer, H. Y., Desnyder, R., Cooremans, W. and Scharpe, S. (1997). Acute phase proteins in schizophrenia, mania and major depression: modulation by psychotropic drugs. Psychiatry Research, 66, 1-11.
32. Maes, M., Song, C., Lin, A., Pioli, R., Kenis, G., Kubera, M. and Bosmans, E. (1998). In vitro immunoregulatory effects of lithium in healthy volunteers. Psychopharmacology, (in press).
33. Mant, M. J., Akabutu, J. J. and Herbert, F. A. (1986). Lithium carbonate in severe Felty's syndrome: benefits, toxicity and granulocyte functions. Archives of Internal Medicine, 146, 277-280.
34. Murphy, D. L., Goodwin, F. K. and Bunney, W. E. (1971). Leukocytosis during lithium treatment. American Journal of Psychiatry, 127, 1559-1561.
35. Nemeroff, C. B., Krishnan, R. R., Blazer, D. G., Knight, D. L., Benjamin, D. and Meyerson, L. R. (1990). Elevated plasma concentrations of alpha-1-acid glycoprotein, a putative endogenous inhibitor of the tritated imipramine binding site, in depressed patients. Archives of General Psychiatry, 47, 337-340.
36. Pavuluri, M. N., Smith, M. and Luk, S. L. (1996). A neuroimmune hypothesis for the aetiopathology of viral illness and manic depression: a case report of an adolescent. Journal of Affective Disorders, 39, 7-11.
37. Randall, S., Hartley, C. E., Buchan, A., Lancaster, S. Aand Skinner, G. R. B. (1991). Effect of lithium on viral replication. Lithium and the Cell: Pharmacology and Biochemistry, Birch, N. J. (Ed.), Academic Press, London, pp. 99-112.
38. Rimon, R., Halonen, P., Anttinen, E. and Evola, K. (1971). Complement fixing antibody to herpes simplex virus in patients with psychotic depression. Diseases of the Nervous System, 32, 822-824.
39. Roberts, D. E., Berman, S. M., Nakasato, S., Wyle, F. A., Wishnow, R. M. and Segal, G. P. (1988). Effect of lithium carbonate on zidovudine-associated neutropenia in the acquired immunodeficiency syndrome. American Journal of Medicine, 85, 428-441.
40. Rybakowski, J. K. and Amsterdam, J. D. (1991). Lithium prophylaxis and recurrent labial herpes infections. Lithium, 2, 43-47.
41. Rybakowski, J., Gwieździński, Z. and Urbanowski, S. (1991). Lithium succinate ointment in topical treatment of herpes simplex infections. Lithium, 2, 117-118.
42. Rybakowski, J. K., Amsterdam, J. D. and Prystowsky, M. D. (1993). Blood cell indices in affective patients during lithium prophylaxis. Lithium, 4, 205-209.
43. Rybakowski, J. K., Żelechowska-Ruda, E. and Chłopocka-Woźniak, M. (1996). The effect of prophylactic lithium administration on the recurrences of labial herpes and affective illness. In Lithium: Biochemical and Clinical Advances, Gallicchio, V. S. and Birch, N. J. (Eds), Weidner Publishing Group, Cheshire, CT, pp. 135-140.
44. Schleifer, S. J., Keller, S. E., Meyerson, A. T., Raskin, D., Davis, K. L. and Stein, M. (1984). Lymphocyte function in major depressive disorder. Archives of General Psychiatry, 41, 484-486.
45. Sengar, D. P. S., Waters, B. G. H., Dunne, J. V. and Bower, I. H. (1982). Lymphocyte subpopulations and mitogenic responses of lymphocytes in manic-depressive disorders. Biological Psychiatry, 17, 1017-1022.
46. Shenkman, L., Borkowsky, W., Holzman, R. and Shopsin, B. (1978). Enhancement of lymphocyte and macrophage function in vitro by lithium chloride. Clinical Immunology and Immunopathology, 10, 187-192.
47. Shopsin, B., Friedman, R. and Gershon, S. (1971). Lithium and leukocytosis. Clinical Pharmacology and Therapeutics, 12, 923-928.
48. Skinner, G. R. B. (1983). Lithium ointment for genital herpes. Lancet, ii, 288.
49. Skinner, G. R. B., Hartley, C., Buchan, A., Harper, L. and Gallimore, P. (1980). The effect of lithium chloride on the replication of Herpes simplex virus. Medical Microbiology and Immunology, 168, 258-265.
50. Służewska, A. and Rybakowski, J. (1993). Cortisol levels and immunological indices in depression. Neuropsychopharmacology, 9, 107S.
51. Służewska, A., Rybakowski, J. K., Sobieska, M. and Wiktorowicz, K. (1994). The effects of lithium carbamazepine and fluoxetine on alpha-1-acid glycoprotein concentration and microheterogeneity in depressed patients. Neuropsychopharmacology, 10 (3S), 202.
52. Służewska, A., Rybakowski, J., Sobieska, M. and Chłopocka-Woźniak, M. (1995a). Effect of prophylactic treatment with lithium on acute phase proteins. Polish Journal of Pharmacology, 47 (suppl), 43.
53. Służewska, A., Rybakowski, J. K., Bosmans, E., Maes, M., Berghmans, R. and Pollet, H. (1995b). The effects of treatment with lithium and carbamazepine on some interleukins and their receptors in depressed patients. Pharmacology Research, 3, 366.
54. Służewska, A., Rybakowski, J. K., Sobieska, M., Bosmans, E., Pollet, H. and Wiktorowicz, K. (1995c). Increased levels of alpha-1-acid glycoprotein and interleukin-6 in refractory depression. Depression, 3, 170-175.
55. Służewska, A., Rybakowski, J. K., Sobieska, M. and Wiktorowicz, K. (1996). Concentration and microheterogeneity glycophorms of alpha-1-acid glycoprotein in major depressive disorder. Journal of Affective Disorders, 39, 149-155.
56. Służewska, A., Sobieska, M. and Rybakowski, J. K. (1997). Changes in acute phase proteins during lithium potentiation of antidepressants in refractory depression. Neuropsychobiology, 35, 123-127.
57. Służewska, A., Rybakowski, J. and Suwalska, A. (1998). Viral rectivation in relation to immune activation in major depression. European Neuropsychopharmacology, 8 (suppl. 2), S187-S188.
58. Straus, S. E., Tosato, G., Armstrong, G., Lawley, T., Preble, O. T., Henle, W., Davey, R., Pearson, G., Epstein, J. and Brus, I. (1985). Persisting illness and fatigue in adults with evidence of Epstein-Barr Virus infection. Annals of Internal Medicine, 102, 7-16.
59. Suwalska, A. and Rybakowski, J. (1998). Potentiation of antidepressants with lithium or carbamazepine: factors associated with therapeutic efficacy. European Neuropsychopharmacology, 8 (suppl. 2), S157-S158.
60. Weetman, A. P., McGregor, A. M., Lazarus, J. H., Rees-Smith, B. and Hall, R. (1982). The enhancement of immunoglobulin synthesis by human lymphocytes with lithium. Clinical Immunology and Immunopathology, 22, 400-407.
61. Wilson, R., McKillop, J. H., Crocket, G. T., Pearson, C., Jenkins, C., Burns, F., Burnett, A. K. and Thomson, J. A. (1991). The effect of lithium therapy on parameters thought to be involved in the development of autoimmune thyroid disease. Clinical Endocrinology, 34, 357-361.
62. Wu, Y. and Yang, X. (1991). Enhancement of interleukin 2 production in human and gibbon T cells after in vitro treatment with lithium. Proceedings of the Society of Experimental Biology and Medicine, 198, 620-624.
63. Ziaie, Z. and Kefalides, N. A. (1989). Lithium chloride restores host protein synthesis in herpes simplex virus infected endothelial cells. Biochemical and Biophysical Research Communications, 160, 1073-1078.
64. Ziaie, Z., Brünker, J. M. and Kefalides, N. A. (1994). Lithium chloride suppressed the synthesis of messenger RNA for infected cell protein-4 and viral deoxyribonucleid acid polymerase in herpes simplex virus infected endothelial cells. Laboratory Investigation, 70, 29-38.
65. Zorzenon, M., Colle, R., Vecchio, D., Bertoli, M., Giavedoni, A., Degrassi, A., Lavaroni, S. and Aguglia, E. (1996). Major depression, viral reactivation and immune system. European Psychiatry, 11 (Suppl. 4), 332s-333s.